Treatment of sensory-neural deafness and tinnitus with a nucleic acid derivative.
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002794:Choline / Q000008:administration & dosage / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003597:Cytosine Nucleotides / Q000008:administration & dosage / Q000627:therapeutic use*; D003638:Deafness / Q000188:drug therapy*; D005260:Female; D006320:Hearing Tests; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D010919:Placebos; D011304:Presbycusis / Q000188:drug therapy; D014012:Tinnitus / Q000188:drug therapy*; D014717:Vertigo / Q000188:drug therapy
D003597:Cytosine Nucleotides; D010919:Placebos; D002794:Choline